Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
Simonet
M
M
Service de Microbiologie, CHU Necker-Enfants Malades, Paris, France.
Moittie
D
D
Philippon
A
A
Descamps
P
P
Veron
M
M
D000658:Amoxicillin / Q000494:pharmacology*; D002969:Clavulanic Acids / Q000494:pharmacology*; D004357:Drug Synergism; D006193:Haemophilus influenzae / Q000187:drug effects / Q000201:enzymology*; D008826:Microbial Sensitivity Tests; D010397:Penicillanic Acid / Q000494:pharmacology*; D010403:Penicillin Resistance; D013407:Sulbactam / Q000494:pharmacology*; D000078142:Tazobactam; D065093:beta-Lactamase Inhibitors
D002969:Clavulanic Acids; D065093:beta-Lactamase Inhibitors; D000658:Amoxicillin; D010397:Penicillanic Acid; D013407:Sulbactam; D000078142:Tazobactam